Nathalie Andrieu-Abadie

INSERM U1065

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Collaborators (3)

Bruno Ségui

Université Paul Sabatier

Jérôme Stirnemann

Assistant Professor

University Hospital of Geneva

Olivier Micheau

Université de Bourgogne

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nathalie Andrieu-Abadie

Research Interests

Explore related searches

Contact this professor

Articles (14)

Collaborators (3)

Bruno Ségui

Jérôme Stirnemann

Olivier Micheau

Make your next move.

Nathalie Andrieu-Abadie

Research Interests

Explore related searches

Contact this professor

Articles (14)

A fluorogenic substrate for the detection of lipid amidases in intact cells

Contribution of Keratinocytes in Skin Cancer Initiation and Progression

A fluorogenic substrate for the detection of lipid amidases in intact cells

Sphingolipid paracrine signaling impairs keratinocyte adhesion to promote melanoma invasion

Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer

Adipocyte Extracellular Vesicles Decrease p16INK4A in Melanoma: An Additional Link between Obesity and Cancer

Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial

Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives

New Insights into the Role of Sphingolipid Metabolism in Melanoma

New Insights into the Role of Sphingolipid Metabolism in Melanoma

Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

Collaborators (3)

Bruno Ségui

Jérôme Stirnemann

Olivier Micheau

Make your next move.